Literature DB >> 20061630

Is frontotemporal lobar degeneration a rare disorder? Evidence from a preliminary study in Brescia county, Italy.

Barbara Borroni1, Antonella Alberici, Mario Grassi, Marinella Turla, Orazio Zanetti, Angelo Bianchetti, Giorgio Dalla Volta, Renzo Rozzini, Nicola Gilberti, Giuseppe Bellelli, Alessandro Padovani.   

Abstract

Frontotemporal Lobar Degeneration (FTLD) has always been considered a rare disorder, but only a few epidemiologic studies are available. The aim of the present work was to ascertain all FTLD patients in a Northern Italy area from January 2001 to December 2008, and to estimate the disease prevalence. On the census day, 213 FTD patients were still alive, resulting in an overall prevalence of 17.6 per 100,000 inhabitants. The prevalence of FTLD in patients aged 45-65 years was 22 per 100,000 inhabitants (95% CI=17-27). The prevalence of FTLD was the highest in patients aged 66-75 (78 per 100,000 inhabitants, 95% CI=56-100), and it was still high over 75 years (54 per 100,000 inhabitants, 95% CI=36-69). FTLD is a more common form of dementia than previously recognized. Our results claimed that FTLD is not only an early-onset disorder, but it is frequent in advanced age as well.

Entities:  

Mesh:

Year:  2010        PMID: 20061630     DOI: 10.3233/JAD-2010-1208

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  21 in total

1.  Frontotemporal Dementia: A Cross-Cultural Perspective.

Authors:  Chiadi U Onyike; Shunichiro Shinagawa; Ratnavalli Ellajosyula
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The behavioral variant of frontotemporal dementia: linking neuropathology to social cognition.

Authors:  Chiara Cerami; Stefano F Cappa
Journal:  Neurol Sci       Date:  2013-02-03       Impact factor: 3.307

Review 3.  The epidemiology of frontotemporal dementia.

Authors:  Chiadi U Onyike; Janine Diehl-Schmid
Journal:  Int Rev Psychiatry       Date:  2013-04

Review 4.  Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis.

Authors:  Ashley F Curtis; Mario Masellis; Ging-Yuek Robin Hsiung; Rahim Moineddin; Kathy Zhang; Bonnie Au; Geneva Millett; Ian Mackenzie; Ekaterina Rogaeva; Mary C Tierney
Journal:  Neurology       Date:  2017-09-15       Impact factor: 9.910

5.  Prevalence of frontotemporal lobar degeneration in an isolated population: the Vallecamonica study.

Authors:  Nicola Gilberti; Marinella Turla; Antonella Alberici; Valeria Bertasi; Patrizia Civelli; Silvana Archetti; Alessandro Padovani; Barbara Borroni
Journal:  Neurol Sci       Date:  2011-11-30       Impact factor: 3.307

6.  Sample size calculations for clinical trials targeting tauopathies: a new potential disease target.

Authors:  Jennifer L Whitwell; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Nirubol Tosakulwong; Stephen D Weigand; Matthew L Senjem; Anthony J Spychalla; Jeffrey L Gunter; Ronald C Petersen; Clifford R Jack; Keith A Josephs
Journal:  J Neurol       Date:  2015-06-17       Impact factor: 4.849

Review 7.  Frontotemporal dementia: a bridge between dementia and neuromuscular disease.

Authors:  Adeline S L Ng; Rosa Rademakers; Bruce L Miller
Journal:  Ann N Y Acad Sci       Date:  2014-12-30       Impact factor: 5.691

8.  Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia.

Authors:  Andrew E Arrant; Anthony J Filiano; Daniel E Unger; Allen H Young; Erik D Roberson
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

9.  Estimating the number of persons with frontotemporal lobar degeneration in the US population.

Authors:  David S Knopman; Rosebud O Roberts
Journal:  J Mol Neurosci       Date:  2011-05-17       Impact factor: 3.444

Review 10.  Imaging frontotemporal lobar degeneration.

Authors:  Janine Diehl-Schmid; Oezguer A Onur; Jens Kuhn; Traugott Gruppe; Alexander Drzezga
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.